This inventor holds 2 USPTO granted patents. Top assignee: Sigilon Therapeutics, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Marianthi Papakosta: Innovator in Fabry Disease Treatment
Introduction
Marianthi Papakosta is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of biotechnology, particularly in the treatment of rare diseases. With a focus on innovative solutions, she has been instrumental in advancing medical research and therapies.
Latest Patents
Marianthi holds 2 patents, with her latest inventions including "Compositions, Devices, and Methods for Treating Fabry Disease" and "Monoclonal Cell Lines Expressing an Exogenous Substance and Uses Thereof." These patents reflect her commitment to developing effective treatments for patients suffering from Fabry disease.
Career Highlights
Currently, Marianthi is associated with Sigilon Therapeutics, Inc., where she continues to push the boundaries of medical innovation. Her work is characterized by a dedication to improving patient outcomes through cutting-edge research and development.
Collaborations
Throughout her career, Marianthi has collaborated with talented professionals, including Guillaume Carmona and Jared A Sewell. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.
Conclusion
Marianthi Papakosta is a trailblazer in the field of biotechnology, with a focus on treating Fabry disease. Her innovative patents and collaborative efforts highlight her significant impact on medical research and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile